2014-12-11 |
1 |
Complaint |
expiration of U.S. Patent Nos. 6,858,576 (the “’576 patent”), 6,872,700
(the “’700 patent”), 6,956,026 (the…Paragraph IV Certification Concerning U.S. Patent Nos.
6,858,576, 6,872,700, 6,902,744, 6,956,026, 7,297,761…of the ’576 patent, the ’700 patent,
the ’026 patent, the ’744 patent, and the ’423 patent (collectively…(the “’026 patent”), 7,297,761 (the “’761 patent”), 6,902,744 (the
“’744 patent”), 7,521,423 (the “’423… This action is for patent infringement, brought pursuant to the patent laws of the
United States |
External link to document |
2015-02-08 |
16 |
Answer to Counterclaim |
United States Patent No. 6,858,576
19. Plaintiffs repeat and… United States Patent No. 6,858,576
39. Plaintiffs repeat and…744 patent and at times to the ’423 patent. To the
extent paragraph 57 refers to the ’744 patent, Plaintiffs…744 patent and at times to the ’423 patent. To the
extent paragraph 58 refers to the ’744 patent, Plaintiffs…the ’576, ’700, ’026, ’744 and ’423 patents and two other patents. Plaintiffs further admit that
Teva |
External link to document |
2014-12-11 |
4 |
Patent/Trademark Report to Commissioner |
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,858,576; 6,872,700; 6,956,026…2014
27 June 2016
1:14-cv-01478
830 Patent
None
District Court, D. Delaware
|
External link to document |
2015-06-08 |
41 |
Notice of Service |
Identification of Asserted Claims of U.S. Patent Nos. 7,297,761 & 7,741,269 filed by Amylin Pharmaceuticals…2014
27 June 2016
1:14-cv-01478
830 Patent
None
District Court, D. Delaware
|
External link to document |
2015-06-29 |
43 |
SO ORDERED |
serve its invalidity contentions as to U.S. Patent Nos. 6,858,576;
6,872,700; 6,956,026; 7,741,269…non-
infringement contentions as to U.S. Patent Nos. 7,297,761 and 7,741,269 is extended to
… to serve its infringement contentions for U.S. Patent Nos.
7,297,761 and 7,741,269 is extended…2014
27 June 2016
1:14-cv-01478
830 Patent
None
District Court, D. Delaware
|
External link to document |